文献速递肝病消化道肿瘤与早癌

1992-2018年美国肝细胞癌发病率和死亡率的种族/民族差异

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
PubMed 文献 · Hepatology · 2022-04-22

该研究基于监测、流行病学和最终结果(SEER)项目数据,分析1992至2018年美国肝细胞癌(HCC)年龄标化发病率与死亡率趋势。2015至2018年总体发病率显著下降(APC -5.6%),2013至2018年死亡率下降(APC -2.2%)。非西班牙裔黑人和美国印第安人/阿拉斯加原住民发病率未显著下降或显著上升。

要点

  • 2015-2018年HCC总体发病率显著下降,APC为-5.6%。
  • 非西班牙裔黑人发病率未显著下降(APC -0.7),美国印第安人/阿拉斯加原住民显著上升(APC +4.3%)。
  • 2013-2018年HCC死亡率下降,APC为-2.2%。

核心结论

  • 2015年起多数人群HCC发病率和死亡率开始下降,但种族/民族间差异持续存在。
  • 非西班牙裔黑人发病率未显著下降,美国印第安人/阿拉斯加原住民发病率显著上升,提示需加大力度减轻这些脆弱人群的HCC负担。

研究设计与样本

  • 使用监测、流行病学和最终结果(SEER)项目的HCC发病率和基于发病率的死亡率数据。
  • 按种族/民族、性别和年龄计算年龄标化率。
  • 采用joinpoint回归估计年度百分比变化(APC),并用年龄-时期-队列模型评估年龄、日历时期和出生队列对趋势的影响。

主要发现

  • 2015至2018年总体HCC发病率显著下降,APC为-5.6%。
  • 大多数组发病率下降,在亚洲/太平洋岛民、女性和<50岁人群中最为明显。
  • 非西班牙裔黑人发病率未显著下降(APC -0.7),美国印第安人/阿拉斯加原住民发病率显著上升(APC +4.3%)。
  • 出生队列对率的影响大于日历时期,婴儿潮队列中1950-1954队列率最高。
  • 2013至2018年HCC死亡率下降,APC为-2.2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: HCC is characterized by racial/ethnic disparities in rates. Recent USA reports suggest that incidence has begun to decline, but it is not clear whether the declines have occurred among all groups, nor whether mortality has declined. Thus, the current study examined USA incidence and mortality between 1992 and 2018. APPROACH & RESULTS: HCC incidence and incidence-based mortality data from the Surveillance, Epidemiology, and End Results program were used to calculate age-standardized rates by race/ethnicity, sex, and age. Trends were analyzed using joinpoint regression to estimate annual percent change (APC). Age-period-cohort models assessed the effects on trends of age, calendar period, and birth cohort. Overall, HCC incidence significantly declined between 2015 and 2018 (APC, -5.6%). Whereas most groups experienced incidence declines, the trends were most evident among Asians/Pacific Islanders, women, and persons <50 years old. Exceptions were the rates among non-Hispanic Black persons, which did not significantly decline (APC, -0.7), and among American Indians/Alaska Natives, which significantly increased (APC, +4.3%). Age-period-cohort modeling found that birth cohort had a greater effect on rates than calendar period. Among the baby boom cohorts, the 1950-1954 cohort had the highest rates. Similar to the overall incidence decline, HCC mortality rates declined between 2013 and 2018 (APC, -2.2%). CONCLUSIONS: HCC incidence and mortality rates began to decline for most groups in 2015, but persistent differences in rates continued to exist. Rates among non-Hispanic Black persons did not decline significantly, and rates among American Indians/Alaska Natives significantly increased, suggesting that greater effort is needed to reduce the HCC burden among these vulnerable groups.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Alvarez CS, Petrick JL, Parisi D, et al. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018. Hepatology. 2022. PMID: 35124828. doi:10.1002/hep.32394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。